162 related articles for article (PubMed ID: 11408045)
1. Negative functional effects of cGMP mediated by cGMP protein kinase are reduced in T4 cardiac myocytes.
Engel S; Yan L; Weiss H; Scholz P
Eur J Pharmacol; 2001 Jun; 421(1):23-30. PubMed ID: 11408045
[TBL] [Abstract][Full Text] [Related]
2. Cyclic GMP reduces ventricular myocyte stunning after simulated ischemia-reperfusion.
Gandhi A; Yan L; Scholz PM; Huang MW; Weiss HR
Nitric Oxide; 1999 Dec; 3(6):473-80. PubMed ID: 10637126
[TBL] [Abstract][Full Text] [Related]
3. Cyclic GMP protein kinase activity is reduced in thyroxine-induced hypertrophic cardiac myocytes.
Yan L; Zhang Q; Scholz PM; Weiss HR
Clin Exp Pharmacol Physiol; 2003 Dec; 30(12):943-50. PubMed ID: 14678234
[TBL] [Abstract][Full Text] [Related]
4. Importance of ryanodine receptors in effects of cyclic GMP is reduced in thyroxine-induced cardiac hypertrophy.
Zhang Q; Goel N; Rodriguez R; Scholz PM; Weiss HR
Eur J Pharmacol; 2006 May; 537(1-3):45-51. PubMed ID: 16626695
[TBL] [Abstract][Full Text] [Related]
5. Interaction between cyclic GMP protein kinase and cyclic AMP may be diminished in stunned cardiac myocytes.
Yan L; Patel KN; Zhang Q; Scholz PM; Weiss HR
Eur J Pharmacol; 2001 Aug; 426(1-2):11-9. PubMed ID: 11525765
[TBL] [Abstract][Full Text] [Related]
6. Effects of cyclic GMP and its protein kinase on the contraction of ventricular myocytes from hearts after cardiopulmonary arrest.
Su J; Scholz PM; Tse J; Weiss HR
Can J Physiol Pharmacol; 2004 Nov; 82(11):986-92. PubMed ID: 15644938
[TBL] [Abstract][Full Text] [Related]
7. Negative inotropic effects of C-type natriuretic peptide are attenuated in hypertrophied ventricular myocytes associated with reduced cyclic GMP production.
Moalem J; Davidov T; Zhang Q; Grover GJ; Weiss HR; Scholz PM
J Surg Res; 2006 Sep; 135(1):38-44. PubMed ID: 16600302
[TBL] [Abstract][Full Text] [Related]
8. Cyclic GMP protein kinase mediates negative metabolic and functional effects of cyclic GMP in control and hypertrophied rabbit cardiac myocytes.
Straznicka M; Gong G; Yan L; Scholz PM; Weiss HR
J Cardiovasc Pharmacol; 1999 Aug; 34(2):229-36. PubMed ID: 10445674
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide and cGMP protein kinase activity in aged ventricular myocytes.
Zhang Q; Molino B; Yan L; Haim T; Vaks Y; Scholz PM; Weiss HR
Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2304-9. PubMed ID: 11709396
[TBL] [Abstract][Full Text] [Related]
10. Opposing functional effects of cyclic GMP and cyclic AMP may act through protein phosphorylation in rabbit cardiac myocytes.
Yan L; Lee H; Huang MW; Scholz PM; Weiss HR
J Auton Pharmacol; 2000 Apr; 20(2):111-21. PubMed ID: 11095549
[TBL] [Abstract][Full Text] [Related]
11. Cyclic GMP signaling and regulation of SERCA activity during cardiac myocyte contraction.
Zhang Q; Scholz PM; He Y; Tse J; Weiss HR
Cell Calcium; 2005 Mar; 37(3):259-66. PubMed ID: 15670873
[TBL] [Abstract][Full Text] [Related]
12. Cyclic GMP-induced reduction in cardiac myocyte function is partially mediated by activation of the sarcoplasmic reticulum Ca(2+)-ATPase.
Zhang Q; Yan L; Weiss HR; Scholz PM
Pharmacology; 2002 Feb; 64(2):106-12. PubMed ID: 11803251
[TBL] [Abstract][Full Text] [Related]
13. Interaction between the opposing functional effects of cyclic AMP and cyclic GMP in hypertrophic cardiac myocytes.
Patel KN; Yan L; Gandhi A; Scholz PM; Weiss HR
Basic Res Cardiol; 2001 Feb; 96(1):34-41. PubMed ID: 11215530
[TBL] [Abstract][Full Text] [Related]
14. SERCA inhibition limits the functional effects of cyclic GMP in both control and hypertrophic cardiac myocytes.
Zhang Q; Davidov T; Weiss HR; Scholz PM
Pharmacology; 2009; 83(4):223-30. PubMed ID: 19258738
[TBL] [Abstract][Full Text] [Related]
15. T4-induced cardiac hypertrophy disrupts cyclic GMP mediated responses to brain natriuretic peptide in rabbit myocardium.
Katz E; Zhang Q; Weiss HR; Scholz PM
Peptides; 2006 Sep; 27(9):2276-83. PubMed ID: 16762459
[TBL] [Abstract][Full Text] [Related]
16. Negative functional effects of natriuretic peptides are attenuated in hypertrophic cardiac myocytes by reduced particulate guanylyl cyclase activity.
Meyer M; Zhang Q; Khurana K; Scholz PM; Weiss HR
J Cardiovasc Pharmacol; 2007 Feb; 49(2):100-5. PubMed ID: 17312451
[TBL] [Abstract][Full Text] [Related]
17. Negative functional effects of cyclic GMP are altered by cyclic AMP phosphodiesterases in rabbit cardiac myocytes.
Weiss HR; Lazar MJ; Punjabi K; Tse J; Scholz PM
Eur J Pharmacol; 2003 Nov; 481(1):25-31. PubMed ID: 14637171
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cGMP-dependent protein kinase by the cell-permeable peptide DT-2 reveals a novel mechanism of vasoregulation.
Taylor MS; Okwuchukwuasanya C; Nickl CK; Tegge W; Brayden JE; Dostmann WR
Mol Pharmacol; 2004 May; 65(5):1111-9. PubMed ID: 15102939
[TBL] [Abstract][Full Text] [Related]
19. Cyclic GMP reduces myocardial stunning through non-cyclic GMP protein kinase mechanisms.
Zhang Q; Lazar M; Yan L; He Y; Tse J; Weiss HR; Scholz PM
J Cardiovasc Pharmacol; 2004 Aug; 44(2):235-43. PubMed ID: 15243306
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of phospholipase A2 (PLA2)-dependent Ca2+ signaling in smooth muscle by cAMP- and cGMP-dependent protein kinases. Inhibitory phosphorylation of PLA2 by cyclic nucleotide-dependent protein kinases.
Murthy KS; Makhlouf GM
J Biol Chem; 1998 Dec; 273(51):34519-26. PubMed ID: 9852121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
